Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Prostate cancer | R-HSA-2990872 | map05215 | sulfamethoxazole | 5329 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | sulfamethoxazole | 5329 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | sulfamethoxazole | 5329 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | cloxacillin | 6098 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | cloxacillin | 6098 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | cloxacillin | 6098 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | cloxacillin | 6098 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | cloxacillin | 6098 | drug-path |
| Asthma | R-HSA-444620 | map05310 | cloxacillin | 6098 | drug-path |
| MAPK signaling pathway | R-HSA-9652817 | map04010 | cloxacillin | 6098 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | cloxacillin | 6098 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | cloxacillin | 6098 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | cloxacillin | 6098 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | pentoxifylline | 4740 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | pentoxifylline | 4740 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | pentoxifylline | 4740 | drug-path |
| Shigellosis | 0 | map05131 | pentoxifylline | 4740 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | pentoxifylline | 4740 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | pentoxifylline | 4740 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pentoxifylline | 4740 | drug-path |